[Prospects for the development of new antituberculous drugs putting our hopes on new drug targets].

Novel drug targets in Mycobacterium tuberculosis related to dormancy and virulence are urgently needed.

• Current tuberculosis drugs primarily target metabolic processes essential for bacterial growth outside of host cells.
• New approaches may focus on inhibiting bacterial factors that disrupt immune cell signaling in infected hosts.
• Targeting mycobacterial dormancy mechanisms could lead to more effective treatments for tuberculosis.
• Research is ongoing to establish novel drug targets that could enhance the effectiveness of tuberculosis therapies.

AI simplified